• Vera Therapeutics President and CEO Marshall Fordyce sold 18,500 Class A common shares on Sep. 2.
• Sale price USD 35.12 per share.
• He also exercised options for 18,500 shares at USD 2.9 per share.
• Direct Class A common stock holdings totaled 235,244 shares following the transactions.
• Directly held stock options totaled 507,301 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001859453-26-000014), on September 04, 2026, and is solely responsible for the information contained therein.